Kualitas bukti 4.13/5
Skor tinjauan delapan dimensi terhadap rubrik kualitas . Setiap dimensi dinilai 1–5.
- D1 Dasar sumber
- 3/5
- D2 Otoritas sumber
- 5/5
- D3 Aritmetika
- 5/5
- D4 Ketidakpastian
- 4/5
- D5 Cakupan
- 4/5
- D6 Prosa
- 4/5
- D7 Kejujuran persepsi
- 3/5
- D8 Kelengkapan peringatan
- 5/5
● faktor Anda — klik risiko ini ▾ untuk menampilkan
- Faktor Anda
≈ Sama mungkinnya dengan
Dipersepsikan
Intuisinya hampir universal pro-pengobatan. Orang tua yang memberi bayi mereka dosis paracetamol sebelum janji temu vaksinasi percaya bahwa mereka bertindak penuh perhatian dan protektif — meredakan demam dan kesusahan yang diharapkan agar bayi lebih sedikit menderita. Gagasan bahwa praktik yang umum dan tampaknya tidak berbahaya ini bisa mengurangi imunitas yang justru dirancang untuk diberikan vaksin tidak terpikirkan dalam sebagian besar model mental orang tua. Tidak ada survei skala besar yang secara khusus menanyakan apakah orang tua mengantisipasi kerugian apa pun dari antipiretik profilaksis di sekitar vaksinasi, jadi ini ditandai sebagai intuisi — tetapi arah kualitatifnya jelas: risiko yang dirasakan dari paracetamol profilaksis nyaris-nol, dan manfaat yang dirasakan adalah pencegahan demam yang nyata.
Sumber: intuisi redaksi, bukan hasil survei
Aktual
~26 % GMC antibodi anti-HBs lebih rendah (orang dewasa, vaksin hepatitis B, profilaksis vs. tanpa paracetamol)
orang dewasa sehat usia 18–48 yang menerima seri vaksinasi hepatitis B; kelompok paracetamol profilaksis vs. kelompok kontrol (Doedée et al. 2014 PLoS One, n=496)
Tampilkan perhitungan
Angka ternormalisasi mewakili besarnya pelemahan antibodi alih-alih probabilitas peristiwa biner. Doedée et al. (2014, PLoS One) adalah sumber tunggal yang paling presisi terkuantifikasi: paracetamol profilaksis (diberikan saat vaksinasi, bukan secara reaktif) menurunkan konsentrasi rata-rata geometrik anti-HBs sebesar 26 % versus tanpa paracetamol dalam RCT dewasa 496 orang (5.768 mIU/mL pada kontrol vs. 4.257 mIU/mL pada kelompok profilaksis, p=0,048). Paracetamol terapeutik (diberikan secara reaktif, 6+ jam setelah vaksinasi) tidak memberi efek signifikan (p=0,34), menetapkan waktu sebagai variabel penentu. Dalam RCT bayi yang fundamental (Prymula et al. 2009, Lancet, n=459 bayi Ceko), paracetamol profilaksis menurunkan GMC antibodi untuk semua 10 serotipe vaksin konjugat pneumokokus plus Hib, difteri, tetanus, dan pertaktin setelah seri primer, dengan persistensi hingga booster untuk beberapa antigen. Ambang seroproteksi dipertahankan untuk sebagian besar antigen di sebagian besar studi; satu-satunya kejadian terdokumentasi di mana seroproteksi itu sendiri berkurang secara signifikan adalah untuk serotipe 6B pada kohort bayi Prymula 2009 (% persis tidak dipublikasikan dalam abstrak). Wysocki et al. (2017, Vaccine) mengonfirmasi penurunan GMC untuk 5 dari 13 serotipe PCV13 tetapi mempertahankan seroproteksi untuk semua antigen. Estimasi titik 0,26 berjangkar pada angka HBV Doedée 2014 sebagai kuantifikasi antigen-tunggal terbaik; probabilitas mengalami pelemahan GMC terukur untuk setidaknya satu antigen sepanjang seri primer bayi lengkap secara efektif pasti berdasarkan temuan RCT yang konsisten, tetapi apakah ini berujung pada titer di bawah seroproteksi untuk anak individu mana pun tidak dapat diturunkan dari data tingkat-abstrak yang tersedia. Pita ketidakpastian 0,05–0,80 mencerminkan rentang antara tepi atas «sebagian pelemahan nyaris pasti» dan tepi bawah «kegagalan vaksin klinis jarang terjadi» dari bukti.
Catatan: Entri ini mendokumentasikan temuan yang nyata dan konsisten — paracetamol profil…
Entri ini mendokumentasikan temuan yang nyata dan konsisten — paracetamol profilaksis pada saat vaksinasi menurunkan GMC antibodi untuk berbagai antigen vaksin dalam setiap RCT yang telah mengujinya — tetapi besaran klinisnya tidak pasti. Sebagian besar anak dalam studi yang dipublikasikan tetap mencapai ambang seroproteksi yang diterima; kekhawatirannya adalah tentang daya tahan antibodi dan potensi luasnya perlindungan jangka panjang alih-alih kegagalan vaksin langsung. Variabel kritisnya adalah waktu: paracetamol terapeutik yang diberikan secara reaktif ketika anak benar-benar mengalami demam (6+ jam setelah vaksinasi) tidak menghasilkan efek pelemahan yang sama baik dalam uji coba dewasa Doedée 2014 maupun uji coba bayi Wysocki 2017. Ibuprofen memiliki profil pelemahan yang berbeda dari paracetamol — ia menghindari sebagian besar serotipe pneumokokus dalam Wysocki 2017 tetapi mengurangi respons pertusis dan tetanus. Inggris adalah pengecualian yang menonjol: pedoman NHS merekomendasikan tiga dosis paracetamol setelah (bukan sebelum) vaksin MenB pada usia 8 dan 12 minggu karena kombinasi MenB menghasilkan demam pada lebih dari 50 % bayi dan JCVI tidak menemukan efek imunogenisitas dari paracetamol pasca-vaksinasi dengan jadwal spesifik itu. Tidak ada uji coba yang dipublikasikan yang menunjukkan peningkatan insidensi penyakit yang dapat dicegah dengan vaksin secara aktual pada anak yang orang tuanya memberi paracetamol profilaksis — buktinya berada pada tingkat titik akhir pengganti (titer antibodi).
Risiko terkait
Risiko lain dengan tema serupa — untuk menjelajahi ketakutan terkait.
Kenaikan berat badan berlebih
Seberapa besar kemungkinan kenaikan berat badan berlebih selama kehamilan?
Anak tidak divaksinasi & campak
Berapa kemungkinan seorang anak yang tidak divaksinasi terkena campak?
Bayi jatuh
Berapa kemungkinan cedera serius ketika bayi jatuh dari furnitur (sofa, tempat tidur, meja ganti popok)?
Gula-garam bayi dan penyakit dewasa
Seberapa besar gula dan garam tambahan dalam dua tahun pertama kehidupan meningkatkan risiko anak terkena diabetes tipe 2 dan hipertensi di masa dewasa?
Pilih penantang
The fear most parents bring to vaccination is not of the vaccine but of the aftermath: the sore thigh, the inconsolable evening, the fever that arrives around midnight. Paracetamol given prophylactically — before the needle, or at the appointment — is the intuitive hedge. What the intuition misses is that this hedge trades one discomfort against something harder to see: a measurably lower antibody response to the very vaccine just given. Prymula and colleagues’ 2009 Lancet RCT in 459 Czech infants found reduced antibody geometric mean concentrations for all ten pneumococcal conjugate vaccine serotypes plus Hib, diphtheria, tetanus, and pertactin when paracetamol was given prophylactically — with serotype 6B being the only antigen where the seroprotection rate itself (not just the titer level) dropped significantly below controls. A separate adult trial (Doedée et al. 2014, PLoS One, n=496, hepatitis B vaccine) gave the cleanest quantified figure: a 26% lower anti-HBs GMC in the prophylactic group versus no paracetamol (4,257 vs. 5,768 mIU/mL, p=0.048). Therapeutic paracetamol — given only when fever actually appeared — produced no significant GMC difference in the same trial.
The mechanism is still being worked out, but the leading hypothesis involves suppression of inflammatory signaling that is part of the normal post-injection immune cascade — fever being a feature of that cascade, not a mere side-effect. Suppressing the fever suppresses part of the response that produces the antibodies. The CDC now advises against routine prophylactic antipyretics at vaccination specifically because of this, guidance that was updated after the Prymula findings became established. None of this applies to therapeutic use: if a child develops fever after the shot, giving paracetamol reactively is well-supported and does not appear to blunt the immune response.
Where the concern is most and least pronounced: the documented finding applies to prophylactic dosing (given at or before vaccination) with paracetamol — the temporal specificity matters. Ibuprofen has a partially different blunting profile and spares most pneumococcal serotypes in Wysocki’s 2017 replication. Most children in the published trials still cleared the accepted seroprotection thresholds — the outcome measured is antibody level, not vaccine-preventable disease incidence — so the clinical magnitude is real but not yet translatable into a clean case-fatality or disease-probability figure. The UK is a specific evidence-based exception: NHS guidance recommends paracetamol after (not before) the MenB vaccine at 8 and 12 weeks because that particular combination produces fever in more than half of infants, and the relevant immunogenicity studies found no blunting under that post-vaccination protocol.
Fakta terkait
Memberikan parasetamol secara profilaksis saat vaksinasi menurunkan respons antibodi sekitar 26% dalam uji terkendali. Pemberian secara reaktif beberapa jam kemudian tidak memberi efek bermakna; variabelnya adalah waktu, bukan obatnya sendiri.
Buku besar klaim
Setiap angka di bawah ini adalah apa yang dilaporkan masing-masing sumber, dengan kutipan kata demi kata yang kami andalkan dan bagaimana kami sampai pada angka kami. Klik tautan mana saja untuk memverifikasi langsung.
3/4 sumber diverifikasi secara independen kata demi kata terhadap sumber terkutip
-
[1] The Lancet (Prymula R et al.) — Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials Terverifikasi
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials- Statistik
Fever ≥38°C: 42% (paracetamol) vs. 66% (control) after primary series; antibody GMCs significantly lower in the prophylactic paracetamol group for all 10 pneumococcal serotypes, protein D, anti-PRP (Hib), anti-diphtheria, anti-tetanus, and anti-pertactin after primary vaccination; seroprotection for serotype 6B significantly lower in paracetamol group- Kutipan
“"Although febrile reactions significantly decreased, prophylactic administration of antipyretic drugs at the time of vaccination should not be routinely recommended since antibody responses to several vaccine antigens were reduced." ”
- Data sumber dari
- 2009-10-17
- Diakses
- 2026-05-03 · salinan arsip
- Verifikasi
- Kutipan diambil ulang secara independen dan dikonfirmasi kata demi kata terhadap sumber terkutip selama audit pendasaran kami.
- Perhitungan
- Prymula 2009 is the foundational RCT for this finding: 459 healthy infants randomized to prophylactic paracetamol (three doses every 6–8 hours post-vaccination) vs. no prophylactic treatment across two consecutive trials (primary series + booster). The fever reduction (42% vs. 66%) confirms the drug works for its stated purpose, making the antibody-blunting finding all the more counterintuitive. The abstract confirms significance for all 10 pneumococcal serotypes plus 4 bacterial antigens; the specific GMC percentage reductions per serotype are in the paywalled full text. Serotype 6B is the only antigen for which seroprotection itself (not just GMC) was significantly lower in the paracetamol group — the most clinically concerning finding. Used as the primary anchor for the consistent-blunting-in-infants evidence.
- Independensi
- Prymula 2009 is an independent prospective RCT, distinct from the Doedée 2014 HBV adult study below (different population, different vaccine, different lead investigator and centre); methodology is independently verifiable.
-
[2] PLoS One (Doedée AMCM et al.) — Effects of Prophylactic and Therapeutic Paracetamol Treatment during Vaccination on Hepatitis B Antibody Levels in Adults: Two Open-Label, Randomized Controlled Trials Terverifikasi
Effects of Prophylactic and Therapeutic Paracetamol Treatment during Vaccination on Hepatitis B Antibody Levels in Adults: Two Open-Label, Randomized Controlled Trials- Statistik
Anti-HBs GMC at one month post-second booster: 5768 mIU/mL (control) vs. 4257 mIU/mL (prophylactic paracetamol), a 26% reduction, p=0.048; therapeutic paracetamol: 4958 mIU/mL, not significant (p=0.34); all groups maintained seroprotection (≥10 IU/L) after full series- Kutipan
“"Only prophylactic paracetamol treatment, and not therapeutic treatment, during vaccination has a negative influence on the antibody concentration after hepatitis B vaccination in adults. These findings prompt to consider therapeutic instead of prophylactic treatment to ensure maximal vaccination efficacy and retain the possibility to treat pain and fever after vaccination." ”
- Data sumber dari
- 2014-06-04
- Diakses
- 2026-05-03 · salinan arsip
- Verifikasi
- Kutipan diambil ulang secara independen dan dikonfirmasi kata demi kata terhadap sumber terkutip selama audit pendasaran kami.
- Perhitungan
- This RCT provides the cleanest quantified figure: 26% reduction in anti-HBs GMC when paracetamol is given prophylactically (at time of vaccination) vs. not given. The key methodological contribution is the three-arm design (prophylactic, therapeutic, control), which isolates timing as the causal variable. Therapeutic paracetamol given 6–8 hours after vaccination produced no statistically significant GMC difference (p=0.34). Since all participants in both groups maintained seroprotection, the concern is about antibody durability and future protection breadth, not immediate vaccine failure. The 26% GMC reduction at one month post-series is the most citable single number in this literature and is used as the native stat anchor.
- Independensi
- Conducted in adults (18–48 years) with hepatitis B vaccine, methodologically distinct from the Prymula 2009 infant pneumococcal study. Different lead author (Doedée), independent RCT with separate enrolment, randomisation, and vaccine type. Confirms the finding replicates across age groups and vaccine platforms.
-
[3] US Centers for Disease Control and Prevention — Vaccine Administration — Chapter 6 (CDC Pink Book) Terverifikasi
Vaccine Administration — Chapter 6 (CDC Pink Book)- Statistik
CDC: prophylactic use of antipyretics at time of vaccination is not recommended; some studies suggest these medications might suppress immune response to some vaccine antigens- Kutipan
“"The prophylactic use of antipyretics (e.g., acetaminophen and ibuprofen) before or at the time of vaccination is not recommended. There is no evidence these will decrease the pain associated with an injection. In addition, some studies have suggested these medications might suppress the immune response to some vaccine antigens." ”
- Data sumber dari
- 2024-01-01
- Diakses
- 2026-05-03 · salinan arsip
- Verifikasi
- Kutipan diambil ulang secara independen dan dikonfirmasi kata demi kata terhadap sumber terkutip selama audit pendasaran kami.
- Perhitungan
- CDC explicitly advises against prophylactic antipyretic use at vaccination in the authoritative Pink Book, citing immune-response suppression. This guidance was updated after the Prymula findings became established. The CDC distinguishes prophylactic use (not recommended) from therapeutic use (permissible when symptoms develop). Used as the primary authoritative public-health guidance anchor confirming the clinical concern is recognised by a major national immunisation programme.
- Independensi
- Independent government guidance drawing on the broader immunisation literature; not a reanalysis of the Prymula RCT data.
-
[4] Vaccine (Wysocki J et al.) — A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations
A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations- Statistik
Prophylactic paracetamol reduced IgG for 5 of 13 PCV13 serotypes (3, 4, 5, 6B, 23F); ibuprofen reduced antibody responses to pertussis FHA and tetanus; delayed administration (6–8 hours post-vaccination) showed no effect on vaccine responses for either drug; seroprotection maintained (≥0.35 µg/mL) across all groups- Kutipan
“"Prophylactic antipyretics affect immune responses to vaccines; these effects vary depending on the vaccine, antipyretic agent, and time of administration." ”
- Data sumber dari
- 2017-04-04
- Diakses
- 2026-05-03 · salinan arsip
- Perhitungan
- Wysocki 2017 replicates and refines the Prymula 2009 finding with PCV13 (13-valent rather than 10-valent) and includes ibuprofen as a separate arm. Key additional findings: (1) the blunting is restricted to 5 of 13 serotypes for paracetamol with PCV13, versus all 10 serotypes in Prymula 2009 — indicating vaccine formulation matters; (2) delayed dosing (6+ hours after vaccination) removes the blunting effect entirely; (3) ibuprofen blunts pertussis and tetanus but spares most pneumococcal serotypes. The maintained seroprotection in all groups is reassuring for clinical outcomes but does not negate the concern about antibody level durability over time. Used as the key replication study and timing-evidence source.
- Independensi
- Independent Polish RCT with distinct enrolment, vaccine brand, and antipyretic arms from both the Prymula 2009 and Doedée 2014 studies. Converges on the same core finding via a different methodology.